XOMAP

XOMA (XOMAP)

XOMA Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XOMAP

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/20	20 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAP	XOMA Corporation
2024/06/18	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:XOMAP	XOMA Corporation
2024/06/18	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:XOMAP	XOMA Corporation
2024/06/14	05 : 31	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:XOMAP	XOMA Corporation
2024/06/12	20 : 30	GlobeNewswire Inc.	XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher	NASDAQ:XOMAP	XOMA Corporation
2024/05/31	05 : 43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/16	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/14	20 : 30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20 : 30	GlobeNewswire Inc.	XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	NASDAQ:XOMAP	XOMA Corporation
2024/04/30	20 : 30	GlobeNewswire Inc.	XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	NASDAQ:XOMAP	XOMA Corporation
2024/04/25	20 : 30	GlobeNewswire Inc.	XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMAP	XOMA Corporation
2024/04/03	22 : 00	GlobeNewswire Inc.	XOMA Corporation Announces Closing of Tender Offer	NASDAQ:XOMAP	XOMA Corporation
2024/03/21	20 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAP	XOMA Corporation
2024/03/20	05 : 05	GlobeNewswire Inc.	XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	NASDAQ:XOMAP	XOMA Corporation
2024/03/11	19 : 56	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:XOMAP	XOMA Corporation
2024/03/09	06 : 34	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:XOMAP	XOMA Corporation
2024/03/08	21 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/03/08	21 : 30	GlobeNewswire Inc.	XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMAP	XOMA Corporation
2024/03/05	07 : 24	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:XOMAP	XOMA Corporation
2024/02/28	21 : 30	GlobeNewswire Inc.	XOMA to Present at Upcoming Investor Conferences in March	NASDAQ:XOMAP	XOMA Corporation
2024/02/16	23 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/02/16	22 : 00	GlobeNewswire Inc.	XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right	NASDAQ:XOMAP	XOMA Corporation